Gene: HSPG2
Official Full Name: heparan sulfate proteoglycan 2provided by HGNC
Gene Summary: This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04109 | HSPG2 Knockout cell line (HeLa) | Human | HSPG2 | 1:3~1:6 | Negative | Online Inquiry |
KO04110 | HSPG2 Knockout cell line (HCT 116) | Human | HSPG2 | 1:2~1:4 | Negative | Online Inquiry |
KO04111 | HSPG2 Knockout cell line (HEK293) | Human | HSPG2 | 1:3~1:6 | Negative | Online Inquiry |
KO04112 | HSPG2 Knockout cell line (A549) | Human | HSPG2 | 1:3~1:4 | Negative | Online Inquiry |
HSPG2 Gene Knockout Cell Lines are genetically modified mammalian cell lines in which the heparan sulfate proteoglycan 2 (HSPG2) gene, also known as perlecan, has been selectively disrupted. This gene plays a critical role in various biological processes, including cell adhesion, proliferation, and the assembly of basement membranes, making these cell lines invaluable tools for investigating the physiological and pathological roles of HSPG2 in a variety of contexts.
The primary function of HSPG2 involves its interaction with growth factors, cytokines, and extracellular matrix components, influencing cell signaling pathways and tissue architecture. Knockout of the HSPG2 gene allows researchers to delineate the specific contributions of this proteoglycan in processes such as tumorigenesis, wound healing, and vascular development. By offering a system devoid of HSPG2, these cell lines provide clarity on the molecular underpinnings of diseases that involve perturbations in extracellular matrix composition and function.
Scientifically, HSPG2 Gene Knockout Cell Lines have significant applications in both basic research and translational studies. They are critical for evaluating therapeutic strategies targeting the extracellular matrix and for understanding the complex roles of proteoglycans in cell biology. This is particularly important in cancer research, where HSPG2 has been implicated in tumor growth and metastasis.
One of the distinctive advantages of HSPG2 Gene Knockout Cell Lines is their specificity. Unlike generic cell lines, these models provide a focused approach to explore the loss-of-function effects of a gene that plays multifaceted roles in cell behavior. This specificity leads to more reliable and reproducible results, which are essential for experimental integrity. Furthermore, these knockout cell lines can be readily used in high-throughput screening and gene editing experiments, allowing for efficient investigation into potential therapies.
For researchers and clinicians dedicated to uncovering the mechanisms of disease and developing novel therapeutic strategies, HSPG2 Gene Knockout Cell Lines present an unparalleled resource. By facilitating insights into the biological significance of HSPG2, these cell lines contribute to advancing our understanding of essential cellular processes.
Our company specializes in the development of high-quality, genetically engineered cell lines and has extensive experience in providing robust tools for the scientific community. Trust in our expertise to support your research needs with our fully validated HSPG2 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.